Research programme: antifungals - ASINEX/F2G
Alternative Names: Antifungals research programme - ASINEX/F2GLatest Information Update: 24 Jun 2009
At a glance
- Originator ASINEX; F2G
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 09 Sep 2003 Preclinical trials in Mycoses in United Kingdom (unspecified route)